Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
101
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

The Emergence of Resistance Under Firstline INSTI Regimens

Zhiman Xie1 Nanning Infectious Disease Hospital Affiliated to Guangxi Medical University & The Fourth People’s Hospital of Nanning, Nanning, Guangxi, 530023, People’s Republic of ChinaView further author information
,
Jie Zhou2 Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning, Guangxi, 530021, People’s Republic of China;3 School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
,
Fang Lu2 Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning, Guangxi, 530021, People’s Republic of China;3 School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
,
Sufang Ai1 Nanning Infectious Disease Hospital Affiliated to Guangxi Medical University & The Fourth People’s Hospital of Nanning, Nanning, Guangxi, 530023, People’s Republic of ChinaView further author information
,
Hao Liang2 Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning, Guangxi, 530021, People’s Republic of China;3 School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of China;4 Life Science Institute, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
,
Ping Cui2 Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning, Guangxi, 530021, People’s Republic of China;4 Life Science Institute, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
,
Jianyan Lin1 Nanning Infectious Disease Hospital Affiliated to Guangxi Medical University & The Fourth People’s Hospital of Nanning, Nanning, Guangxi, 530023, People’s Republic of ChinaView further author information
&
Jiegang Huang2 Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning, Guangxi, 530021, People’s Republic of China;3 School of Public Health, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-3271-1694View further author information
ORCID Icon show all
Pages 4269-4274 | Published online: 06 Aug 2022

Figures & data

Table 1 HIV Drug Resistance Genotype Test Results

Figure 1 Patient’s diagnosis and treatment process. Abbreviations:DTG/3TC, dolutegravir/lamivudine; BIC/FTC/TAF, Bictegravir/emtricitabine/tenofovir alafenamide; EFV, efavirenz. LPV/r, lopinavir/ritonavir.

Figure 1 Patient’s diagnosis and treatment process. Abbreviations:DTG/3TC, dolutegravir/lamivudine; BIC/FTC/TAF, Bictegravir/emtricitabine/tenofovir alafenamide; EFV, efavirenz. LPV/r, lopinavir/ritonavir.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.